Azacytidine induced localized Sweets syndrome in Myelodysplastic syndrome.

Suppr

超能文献

作者信息

Dev Tanvi, Dudani Pankhuri, Bhari Neetu

机构信息

Department of Dermatology & Venereology, All India Institute of Medical Sciences, New Delhi, India.

出版信息

Dermatol Ther. 2021 Mar;34(2):e14754. doi: 10.1111/dth.14754. Epub 2021 Jan 18.

DOI:10.1111/dth.14754

PMID:33406304

Abstract

摘要

相似文献

Azacytidine induced localized Sweets syndrome in Myelodysplastic syndrome.

Dermatol Ther. 2021 Mar;34(2):e14754. doi: 10.1111/dth.14754. Epub 2021 Jan 18.

Recurrence of abdominal large-vessel vasculitis and development of severe Sweet syndrome after a single cycle of 5-azacytidine in a patient with myelodysplastic syndrome.

Eur J Haematol. 2014 Apr;92(4):362-4. doi: 10.1111/ejh.12249. Epub 2014 Jan 10.

Azacitidine-induced Sweet syndrome: Two unusual clinical presentations.

Australas J Dermatol. 2018 Aug;59(3):e224-e225. doi: 10.1111/ajd.12727. Epub 2017 Oct 18.

Atypical presentations of Sweet's syndrome in patients with MDS/AML receiving combinations of hypomethylating agents with histone deacetylase inhibitors.

Am J Hematol. 2009 Oct;84(10):688-9. doi: 10.1002/ajh.21510.

Complete remission of Sweet's syndrome after azacytidine treatment for concomitant myelodysplastic syndrome.

Int J Hematol. 2014;99(5):663-7. doi: 10.1007/s12185-014-1527-9. Epub 2014 Feb 20.

Histiocytoid Sweet's syndrome potentially related to decitabine in a patient with myelodysplastic syndrome.

Eur J Dermatol. 2012 Nov-Dec;22(6):811-2. doi: 10.1684/ejd.2012.1861.

Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome.

Ann Hematol. 2015 Nov;94(11):1925-6. doi: 10.1007/s00277-015-2458-0. Epub 2015 Aug 2.

Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome.

Br J Haematol. 2011 Jul;154(1):141-3. doi: 10.1111/j.1365-2141.2010.08438.x. Epub 2011 Feb 20.

Successful treatment of donor cell derived myelodysplastic syndrome with 5-azacytidine.

Ann Biol Clin (Paris). 2017 Dec 1;75(6):713-714. doi: 10.1684/abc.2017.1293.

Azacitidine-associated Sweet's syndrome.

Am J Health Syst Pharm. 2012 May 15;69(10):869-71. doi: 10.2146/ajhp110523.

引用本文的文献

Sweet Syndrome Localized to the Face.

Indian J Dermatol. 2023 Mar-Apr;68(2):222-225. doi: 10.4103/ijd.ijd_961_22.

Azacytidine-induced Sweet's syndrome.

BMJ Case Rep. 2022 Dec 26;15(12):e252329. doi: 10.1136/bcr-2022-252329.

Analysis of the Clinical Efficacy of Azacytidine + Venetoclax in the Treatment of Elderly Patients with Relapsed Refractory Acute Myeloid Leukemia.

Evid Based Complement Alternat Med. 2022 Oct 14;2022:8691835. doi: 10.1155/2022/8691835. eCollection 2022.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验